Direct stimulation of T lymphocytes by immunosomes: virus-like particles decorated with T cell receptor/CD3 ligands plus costimulatory molecules.
Many infectious viruses coevolved with the vertebrate immune system. During the assembly of enveloped viruses, lipid ordered domains of the host cell plasma membrane, called lipid rafts, frequently function as a natural meeting point for viral proteins. The role of lipid rafts in the organization of complex combinations of immune receptors during antigen presentation and T cell signaling is widely recognized. In our studies, we determined whether lipid rafts, virus budding, and molecular interactions during T cell activation could be brought into a novel context to create artificial antigen-presenting particles. We show here that cell-free virus-like particles (VLP) expressing a surrogate TCR/CD3 ligand (OKT3scFv) and the costimulator CD80 polyclonally activate human T cells independently of accessory cells. VLP expressing the glycoprotein epitope 33-41 of the lymphocytic choriomeningitis virus in the context of H-2D(b) activate and expand naïve, antigen-specific CD8(+) T lymphocytes and differentiate them into cytotoxic effector cells. Efficient targeting of T cell ligands to lipid rafts and ultimately to VLP is achieved by C-terminal introduction of glycosyl phosphatidyl inositol acceptor sequences, replacing transmembrane and intracellular domains. In this work, basic functions of immunostimulatory molecules meet virus biology and translate into a reductionist antigen-specific T lymphocyte-stimulating vehicle, which we refer to as immunosomes. A large variety of agonistic and antagonistic accessory molecules on genuine antigen-presenting cells may complicate the predictable manipulation of T cells as well as the analysis of selected receptor combinations, making immunosomes potentially useful reagents for such purposes in the future.
Derdak
Sophia V
SV
Institute of Immunology, Medical University of Vienna, 1090 Vienna, Austria.
Kueng
Hans J
HJ
Leb
Victoria M
VM
Neunkirchner
Alina
A
Schmetterer
Klaus G
KG
Bielek
Edith
E
Majdic
Otto
O
Knapp
Walter
W
Seed
Brian
B
Pickl
Winfried F
WF
D000818:Animals; D017252:CD3 Complex / Q000276:immunology*; D002478:Cells, Cultured; D000939:Epitopes / Q000276:immunology; D017261:Glycosylphosphatidylinositols / Q000378:metabolism; D006801:Humans; D007155:Immunologic Factors / Q000276:immunology; D019169:Jurkat Cells; D008024:Ligands; D008213:Lymphocyte Activation / Q000276:immunology*; D008217:Lymphocytic choriomeningitis virus / Q000737:chemistry* / Q000276:immunology / Q000648:ultrastructure; D021962:Membrane Microdomains / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D011948:Receptors, Antigen, T-Cell / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*; D014771:Virion / Q000276:immunology*
D017252:CD3 Complex; D000939:Epitopes; D017261:Glycosylphosphatidylinositols; D007155:Immunologic Factors; D008024:Ligands; D011948:Receptors, Antigen, T-Cell